Oxford PharmaGenesis, an independent global HealthScience Communications Consultancy, has opened its first office in Switzerland. Dr. Paul Strijbos, an industry professional with 20 years of experience, will lead new office. The company offers a full range of services from its global team of 100 employees.
“I am very excited to be leading this major new contribution to health science in Switzerland,” said Dr. Strijbos. “From orphan drugs to value demonstration, from public policy to regulatory affairs, and from medical communications to publication planning, we offer a comprehensive service based on our long-term global reputation for delivery excellence. I am particularly pleased that Ruth Bentley, an editorial expert with over 25 years of experience, will guide all aspects of client delivery.”
The company's founder, Dr. Graham Shelton, said, “This marks a significant step in the growth of Oxford PharmaGenesis, which now comprises four offices, Oxford, London, Philadelphia and Basel. We believe in developing supportive, long-term relationships with our clients, and this new base in mainland Europe equips us to provide an even higher level of quality service.”